CTIS.eu › Cities › France › St Etienne Cedex 2
St Etienne Cedex 2
France
61 total trials
27 recruiting
2023-509558-80-00
5
Patient with a diagnosis of schizophrenia spectrum disorder (SSD): sch
2024-513801-30-00
5
Recurrent Erysipelas in lower limbs
2024-513889-19-00
5
Multiple Myeloma
2024-514633-38-00
5
Crohn’s Disease
2024-514659-13-00
5
Patients with severe forms of Recurrent Aphthous Stomatitis (RAS)
2024-520391-10-01
5
Obstetrical Brachial Plexus Palsy
2025-521632-12-00
5
Patients on Factor Xa inhibitor treatment needing an urgent interventi
2025-522471-28-00
5
psoriatic arthritis (PsA)
2025-523094-42-00
5
Hirschsprung's disease
2024-519836-18-00
5
2025-12-16
treatment-resistant schizophrenia (TRS)
2025-520982-39-00
5
2025-12-09
Philadelphia Chromosome Positive or ABL-class Philadelphia Chromosome-
2022-502503-30-00
5
2022-12-15
Acute lymphoblastic leukemia
2024-520205-39-00
5
2026-04-21
Traumatic brain injury
2022-501902-36-00
5
2026-01-15
spina bifida
2024-518780-36-00
3
2025-12-10
Systemic Lupus Erythematosus
2024-514954-63-00
9
2025-08-20
RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMAS
2024-514647-29-01
4
2025-07-22
psoriasis
2024-518991-30-00
6
2025-07-17
kidney cancer
2024-516219-25-00
5
2025-03-25
psoriatic arthritis
2023-507227-36-00
5
2025-02-21
SARS-CoV-2 (COVID-19) infection
2023-509787-15-00
5
2025-02-17
Patients with localised prostate cancer and high-risk features of rela
2024-511159-16-00
6
2025-02-14
digital osteoarthritis
2023-504620-26-00
4
2024-11-04
Triple negative breast cancer
2023-508614-41-00
4
2024-10-15
The study will be proposed to all adult patients receiving an allogene
Showing 1–24 of 61 trials